DWM
REGN icon

Drive Wealth Management’s Regeneron Pharmaceuticals REGN Stock Holding History

Drive Wealth Management’s Portfolio REGN Stock Details REGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-420
Closed -$325K – 480
2026
Q1 		$325K Buy
420
+47
+13% +$36K 0.07% 241
2025
Q4 		$288K Buy
+373
New +$253K 0.06% 260
2025
Q1 		– Sell
-339
Closed -$241K – 372
2024
Q4 		$241K Sell
339
-4
-1% -$3.36K 0.06% 262
2024
Q3 		$361K Buy
343
+11
+3% +$12.2K 0.09% 178
2024
Q2 		$349K Buy
332
+8
+2% +$7.75K 0.09% 175
2024
Q1 		$312K Buy
324
+13
+4% +$12.4K 0.09% 195
2023
Q4 		$273K Buy
311
+12
+4% +$9.88K 0.09% 208
2023
Q3 		$246K Buy
+299
New +$235K 0.09% 204
2023
Q2 		– Sell
-245
Closed -$201K – 309
2023
Q1 		$201K Buy
+245
New +$185K 0.08% 258

Other funds holding REGN

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Dodge & Cox
Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Nuveen
Nuveen Charlotte, North Carolina $419B AUM 43.02% 1-Year Est. Return

Drive Wealth Management's REGN Position: Q2 2026 in Review

Drive Wealth Management sold out of Regeneron Pharmaceuticals (REGN) in Q2 2026, closing a stake of 420 shares — an estimated $325K sold.

Drive Wealth Management first reported a position in REGN in Q1 2023 and held it in 9 quarters. The position peaked at $361K in Q3 2024. 1,333 funds tracked by Wall St. Rank hold REGN as of Q2 2026.

  • Drive Wealth Management reported no remaining Regeneron Pharmaceuticals position as of Q2 2026 after selling out during the quarter.
  • Drive Wealth Management sold 420 Regeneron Pharmaceuticals shares in Q2 2026, an estimated $325K.
  • Drive Wealth Management first reported a position in Regeneron Pharmaceuticals in Q1 2023 and held it in 9 quarters.
  • Drive Wealth Management's Regeneron Pharmaceuticals position peaked at $361K in Q3 2024.
  • 1,333 funds tracked by Wall St. Rank held Regeneron Pharmaceuticals as of Q2 2026.

Based on Drive Wealth Management's 13F filing for Q2 2026, filed 22 Jul 2026.